|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02157 LEPU BIO-B
Nominal 
3.010 +0.140 (+4.878%) | 2024/06 - Interim RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | |
| Net Cash from / (used in) Operating Activities | -- | (250,836) | (480,928) | (621,736) | (422,689) |
| Net Cash from / (used in) Investing Activities | -- | 18,256 | (74,663) | (3,892) | (749,669) |
| Net Cash from / (used in) Financing Activities | -- | (11,014) | 1,031,965 | 380,310 | 1,386,679 |
| Increase / (Decrease) in Cash & Cash Equivalents | -- | (243,594) | 476,374 | (245,318) | 214,321 |
| Cash & Cash Equivalents at beginning of period | -- | 669,397 | 155,168 | 402,867 | 188,545 |
| Effect of Foreign Exchange Rate Changes | -- | 212 | 37,855 | (2,381) | 1 |
| Others | -- | 0 | 0 | 0 | 0 |
| Cash & Cash Equivalents at end of period | -- | 426,015 | 669,397 | 155,168 | 402,867 |
| Remarks: | Real time quote last updated: 27/11/2024 16:20 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (¥) | RMB -192,430,000 |
| %Change | 35.606% |
| EPS / (LPS) | RMB -0.120 |
| NBV Per Share (¥) | RMB 0.535 |